Self-sealing plugs market seen growing 7.4% annually by 2030

The market for self-sealing plugs used in arterial blood collection is projected to rise from $0.13 billion in 2025 to $0.18 billion by 2030, according to The Business Research Company. Growth is being driven by more critical care testing, infection-control priorities and rising chronic respiratory disease cases.

Why it matters: - Self-sealing plugs help keep arterial blood samples sealed, sterile and leak-free after collection. - The products reduce contamination risk and lower healthcare workers’ exposure to blood during handling. - Demand is rising because hospitals are putting more focus on safe blood collection and infection prevention.

What happened: - The Business Research Company published a Global Market Report 2026 on self-sealing plugs for arterial blood collection. - The market is projected to grow from $0.13 billion in 2025 to $0.14 billion in 2026. - The report puts the market at $0.18 billion by 2030. - The forecast implies a 7.4% compound annual growth rate from 2026 to 2030. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region during the forecast period.

The details: - Historical growth was supported by more critical care admissions, more arterial blood gas testing, stronger healthcare worker safety measures, hospital diagnostic infrastructure expansion and broader use of disposable medical devices. - Forecast growth is expected to come from demand for advanced safety devices, more investment in critical care diagnostics, infection-prevention technologies, expanded emergency and intensive care capacity and stricter blood-collection rules. - Self-sealing plugs close arterial blood collection devices immediately after blood draw. - The plugs help maintain a closed environment after blood withdrawal, which supports accurate diagnostic testing. - Chronic respiratory diseases such as asthma and chronic obstructive pulmonary disease are increasing demand for arterial blood gas sampling. - In 2024, asthma accounted for 2.5% of Australia’s total disease burden and was the leading cause of disease burden among children ages 1 to 9. - Australia’s healthcare expenses tied to asthma reached about $1.3 billion in 2023-24. - Nearly 96% of acute care hospitals offered arterial blood gas sampling in November 2024, and 63.9% provided comprehensive arterial blood gas analysis services, according to the American Association for Respiratory Care. - In Australia, hospital-acquired complications were recorded in 220,000 cases out of 12.8 million hospitalizations as of June 2026.

Between the lines: - The market outlook tracks a broader shift toward safer, more automated and more infection-conscious clinical workflows. - The strongest use case is in critical care, where fast blood-gas testing and sterile handling are operational necessities rather than optional upgrades. - Rising chronic respiratory disease rates add another layer of demand because patients often need repeated monitoring.

What's next: - The market is likely to benefit as emergency and intensive care capacity expands. - Hospitals and device makers will likely keep emphasizing infection control, worker safety and closed-system sampling. - Regional growth should stay strongest in Asia-Pacific as healthcare infrastructure and critical care diagnostics expand.

The bottom line: - Self-sealing plugs are a small but increasingly important part of blood-collection systems, and the market is expected to keep growing steadily through 2030.